Impact of a Two-Filter Cerebral Embolic Protection Device on the Complexity and Risk of Transcatheter Aortic Valve Replacement.
Stephanie VossMarcus-André DeutschJohanna SchechtlMagdalena ErlebachKonstantinos SiderisRüdiger LangeSabine BleizifferPublished in: The Thoracic and cardiovascular surgeon (2019)
Our data add evidence that the application of the CS-EPD is not associated with an additional risk for the patient. Although procedural time and amount of contrast are still higher when using the CS-EPD, there were no device-related complications or increased incidence of renal failure.
Keyphrases
- transcatheter aortic valve replacement
- aortic stenosis
- aortic valve
- risk factors
- magnetic resonance
- subarachnoid hemorrhage
- case report
- electronic health record
- big data
- magnetic resonance imaging
- contrast enhanced
- cerebral ischemia
- brain injury
- coronary artery disease
- ejection fraction
- deep learning
- artificial intelligence